Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
2013
Objective
The objective of this study was to assess the response to abatacept at doses of 2 mg/kg and 10 mg/kg compared to placebo in patients with active rheumatoid arthritis (RA) with an inadequate clinical response to methotrexate (MTX).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
27
Citations
NaN
KQI